2-240895868-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001085437.3(MAB21L4):c.130C>T(p.Leu44Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,556,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001085437.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAB21L4 | NM_001085437.3 | c.130C>T | p.Leu44Phe | missense_variant | 1/5 | ENST00000388934.5 | NP_001078906.3 | |
MAB21L4 | XM_011511877.2 | c.130C>T | p.Leu44Phe | missense_variant | 2/6 | XP_011510179.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAB21L4 | ENST00000388934.5 | c.130C>T | p.Leu44Phe | missense_variant | 1/5 | 2 | NM_001085437.3 | ENSP00000373586 | P1 | |
MAB21L4 | ENST00000414499.1 | c.130C>T | p.Leu44Phe | missense_variant | 2/2 | 4 | ENSP00000390935 | |||
MAB21L4 | ENST00000454476.2 | c.100C>T | p.Leu34Phe | missense_variant | 2/2 | 5 | ENSP00000394874 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152270Hom.: 0 Cov.: 34
GnomAD4 exome AF: 0.0000107 AC: 15AN: 1404608Hom.: 0 Cov.: 64 AF XY: 0.00000723 AC XY: 5AN XY: 691100
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152270Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74396
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.130C>T (p.L44F) alteration is located in exon 1 (coding exon 1) of the C2orf54 gene. This alteration results from a C to T substitution at nucleotide position 130, causing the leucine (L) at amino acid position 44 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at